New Delhi: The Union Health Ministry, on Tuesday (January 17), refuted the media reports claiming admission of ‘multiple side-effects of COVID-19 vaccines’ by Indian Council of...
Covovax is actually the best booster because it works very well against Omicron, more than Covishield, said Serum Institute of India's CEO Adar Poonawalla
No discussion has been started even in the Immunisation panel National Technical Advisory Group on Immunisation (NTAGI) regarding the second booster dose, an official source told...
People previously infected with the SARS-CoV-2 virus still benefit from vaccination against COVID-19, gaining 60 per cent to 94 per cent protection against reinfection, according to...
Because of its incredible manufacturing capacity, (India) has been a major exporter of vaccines, said Dr Ashish Jha, White House Coronavirus Response Coordinator
Bill & Melinda Gates Foundation CEO Mark Suzman, said that India showed great examples on how to continue its own development trajectory notwithstanding various challenges including...
Earlier, Bharat Biotech had announced the approval for its iNCOVACC (BBV154), the world’s first intranasal COVID-19 vaccine, from the DCGI for restricted use in emergencies for...
The study said that people who received at least two doses of the COVID-19 vaccination compared to those who received none experienced 8 of the 10...
The world's first intranasal COVID-19 vaccine, iNCOVACC, received approval from DCGI under restricted use in emergency situations for ages 18 and above
According to Dr NK Arora Chairperson of COVID-19 working group NTAGI, the whole concept of next-generation vaccine is that we don't have to give repeated doses
The research, published in the New England Journal of Medicine, analysed the probability of vaccinated people becoming infected with the omicron subvariant BA.5
Novavax के सहयोग से सीरम इंस्टीट्यूट ऑफ इंडिया ओमिक्रॉन के एक सब-वेरिएंट BA.5 के लिए वैक्सीन पर काम कर रहा है
